Archive for July, 2008
« Previous EntriesNew Entry Genetic Markers May Predict Lung Cancer Recurrence (healthday)
Thursday, July 31st, 2008HealthDay - WEDNESDAY, March 12 (HealthDay News) — Certain geneticalterations in tumors and tissue from patients with early-stage lungcancer may identify those at greatest risk for cancer recurrence, sayresearchers at the Johns Hopkins Kimmel Cancer Center. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new […]
Your Comments? Bsd-2000 Cancer Treatment System By Bsd Medical Installed In Prestigious Liaocheng Peoples Hospital In China
Thursday, July 31st, 2008BSD Medical Corp. (NASDAQ:BSDM) announced that another BSD-2000 hyperthermia system has been purchased, installed and is now in use in China, at the Liaocheng Peoples Hospital located in Liaocheng City, in the Western Shandong Province of the People’s Republic of China. The Liaocheng Peoples Hospital has recently added a 19-floor, state-of-the-art building equipped with the […]
Updated Maine Governor Supports Cigarette Tax Increase To Fund State Health Program
Wednesday, July 30th, 2008Maine Gov. John Baldacci (D) on Tuesday announced that he supports a proposed 50-cent-per-pack cigarette tax increase to fund the state Dirigo Health program, Blethen Maine/Portland Press Herald reports. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Important Ovarian Cancer Stem Cells Identified, Characterized And Cloned, Leading To More Effective Treatment
Tuesday, July 29th, 2008Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer’s recurrence and its resistance to chemotherapy. “These results bring us closer to more effective and targeted treatment for epithelial ovarian […]
Join The Fight Against Cancer Some Breast Cancers Don't Respond To Chemotherapy (reuters)
Tuesday, July 29th, 2008Admin wrote: Reuters - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy. (Link)
This entry was important to me:
These icons link to social […]
New Amount Of Her-2 Gene Amplification As Assessed By Fish Is Linked To Magnitude Of Survival Benefit In Patients With Locally Advanced Breast Cancer
Monday, July 28th, 2008Today, Patients with locally advanced breast cancers whose tumours contain high numbers of copies of the gene for the human epidermal growth factor receptor 2 (HER-2), as assessed by fluorescence in situ hybridization (FISH), are more likely to have a complete response to treatment with an antibody to the receptor than patients with fewer copies […]
Topic Most Breast Cancer Web Pages Contain Reliable Information (healthday)
Monday, July 28th, 2008HealthDay - MONDAY, Feb. 11 (HealthDay News) — Just 5 percent of Web pagesdevoted to breast cancer contain inaccurate information. But pages focusedon complementary or alternative medicine are 15 times more likely to makemisleading claims and contain other false information, a new studysays. (Link)
This entry was important to me:
These icons link to social bookmarking sites […]
Current Erma’s Recommendation To Continue The Use Of Endosulfan In New Zealand Dismays Breast Cancer Network
Sunday, July 27th, 2008Breast Cancer Network NZ is very disturbed that ERMA has not recommended a ban on the use of the pesticide endosulfan in New Zealand. This acutely toxic organochlorine chemical has been used so widely that it is found in our food and water and is a contaminant of the environment and animal tissues all over […]
Join The Fight Against Cancer Expression Pathology Obtains Maryland Funding To Develop Breast Cancer Test
Saturday, July 26th, 2008Expression Pathology Inc. (EPI), a leader in tissue protein analysis, has obtained $125,000 from the State of Maryland to develop a quantitative test for HER2 protein, an important biomarker in breast cancer tissue samples. The funding is part of the Maryland Technology Development Corporation’s Maryland Technology Transfer Fund (TEDCO MTTF) and the Maryland Venture Fund’s […]
New Entry "psychoeducation" Doesn't Increase Melanoma Survival (reuters)
Friday, July 25th, 2008Reuters - Contrary to earlier findings, a psychoeducational intervention provides no survival benefit and doesn't increase the time between treatment and recurrence in patients with malignant melanoma of the skin, Danish researchers report. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.